MANF Therapeutics Announces Issuance of Patent in Hong Kong Covering Use of MANF for Treatment of Diabetes and Wolfram's
03 mai 2018 09h15 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – MANF Therapeutics, Inc., a wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS) in pre-clinical development...
Elto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive Impairment
01 mai 2018 10h31 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Elto Pharma, Inc., a specialty pharmaceutical, clinical-stage wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc....
Elto PharmaAppoints Paula Trzepacz, MD asChief Medical Advisor
30 avr. 2018 07h00 HE
|
Amarantus Bioscience Holdings, Inc.
Ex-Lilly Sr. Medical Fellow in Neurosciences to lead Parkinson's Phase 2b redesign NEW YORK, April 30, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Elto Pharma, Inc., a specialty pharmaceutical,...
Cutanogen Appoints Richard Kagan, MD as Chief Medical Advisor
23 avr. 2018 08h00 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Cutanogen Corporation, an orphan clinical-stage regenerative medicine wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc....
Amarantus Appoints Michael T. Ropacki, PhD as Chief Medical Advisor for Alzheimer's Blood Diagnostic LymPro Test Program
16 avr. 2018 07h31 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company...
Amarantus to Present at The Microcap Conference in NYC
09 avr. 2018 13h10 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 09, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company...
Amarantus Re-acquires Rights to Alzheimer's Blood Diagnostic LymPro Test
06 avr. 2018 11h24 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 06, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company...
Amarantus Appoints Barney Monte as Interim COO/CFO and Promotes Brian Harvey to Chief Regulatory Advisor
05 avr. 2018 08h00 HE
|
Amarantus Bioscience Holdings, Inc.
NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
Amarantus Relocates Headquarters to WeWork at 110 Wall St. in New York City
02 avr. 2018 09h49 HE
|
Amarantus Bioscience Holdings, Inc.
SAN FRANCISCO, April 02, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTCPink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding...
Amarantus Completes Tender Exchange of Convertible Securities; CEO attending CNBC's Healthy Returns conference in New York City
28 mars 2018 13h41 HE
|
Amarantus Bioscience Holdings, Inc.
SAN FRANCISCO, March 28, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based biotechnology holding company with...